SF
XBI icon

Synovus Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Synovus Financial’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$612K Hold
6,107
– – 0.01% 637
2025
Q2 		$507K Sell
6,107
-389
-6% -$31K 0.01% 662
2025
Q1 		$527K Sell
6,496
-94
-1% -$8.4K 0.01% 646
2024
Q4 		$594K Sell
6,590
-2,801
-30% -$271K 0.01% 596
2024
Q3 		$928K Buy
9,391
+4,939
+111% +$485K 0.01% 527
2024
Q2 		$413K Sell
4,452
-247
-5% -$22.1K 0.01% 662
2024
Q1 		$446K Buy
4,699
+90
+2% +$8.35K 0.01% 645
2023
Q4 		$412K Sell
4,609
-409
-8% -$30.4K 0.01% 652
2023
Q3 		$366K Buy
5,018
+429
+9% +$34.3K ﹤0.01% 689
2023
Q2 		$382K Sell
4,589
-669
-13% -$55.9K ﹤0.01% 678
2023
Q1 		$401K Buy
5,258
+264
+5% +$21.9K ﹤0.01% 661
2022
Q4 		$415K Sell
4,994
-4,708
-49% -$381K ﹤0.01% 656
2022
Q3 		$771K Buy
9,702
+1,098
+13% +$92.6K 0.01% 482
2022
Q2 		$639K Sell
8,604
-6,858
-44% -$515K 0.01% 525
2022
Q1 		$1.39M Buy
15,462
+13,116
+559% +$1.21M 0.01% 390
2021
Q4 		$264K Buy
+2,346
New +$283K ﹤0.01% 772
2020
Q3 		– Sell
-604
Closed -$68K – 1479
2020
Q2 		$68K Sell
604
-963
-61% -$94.8K ﹤0.01% 846
2020
Q1 		$122K Buy
1,567
+780
+99% +$69.1K ﹤0.01% 877
2019
Q4 		$75K Sell
787
-363
-32% -$31.4K ﹤0.01% 866
2019
Q3 		$89K Hold
1,150
– – ﹤0.01% 797
2019
Q2 		$101K Hold
1,150
– – ﹤0.01% 704
2019
Q1 		$104K Sell
1,150
-37
-3% -$3.15K ﹤0.01% 694
2018
Q4 		$86K Sell
1,187
-82
-6% -$6.61K ﹤0.01% 704
2018
Q3 		$122K Buy
1,269
+127
+11% +$12.3K ﹤0.01% 680
2018
Q2 		$109K Hold
1,142
– – ﹤0.01% 674
2018
Q1 		$99K Buy
+1,142
New +$104K ﹤0.01% 680
2017
Q3 		– Sell
-152
Closed -$12K – 761
2017
Q2 		$12K Hold
152
– – ﹤0.01% 728
2017
Q1 		$10K Buy
+152
New +$10.2K ﹤0.01% 955

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Synovus Financial's XBI Position: Q3 2025 in Review

Synovus Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2025 at 6,107 shares worth $612K. The position accounts for 0.01% of the portfolio, ranked #637.

Synovus Financial first reported a position in XBI in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.39M in Q1 2022. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Synovus Financial held 6,107 shares of State Street SPDR S&P Biotech ETF worth $612K as of Q3 2025.
  • Synovus Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2025.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Synovus Financial's portfolio in Q3 2025, its #637 holding.
  • Synovus Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 28 quarters since.
  • Synovus Financial's State Street SPDR S&P Biotech ETF position peaked at $1.39M in Q1 2022.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.